PMID: 6402089Jan 29, 1983Paper

HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis

British Medical Journal
M I GarleppF T Christiansen

Abstract

Antibodies to the acetylcholine receptor and HLA antigens have been studied in patients with myasthenia gravis occurring in association with penicillamine treatment. The properties of the antiacetylcholine receptor in these patients differed from those in patients with idiopathic myasthenia gravis in terms of specificity and affinity. These patients had an increased prevalence of HLA Bw35 and DR1 compared to controls and a decreased frequency of B8 and DR3 compared to patients with idiopathic myasthenia gravis. Likewise, they had a decreased frequency of DR4 compared to patients with rheumatoid arthritis. These data provide supportive evidence for a role for penicillamine in the induction of myasthenia gravis in genetically predisposed individuals.

References

Jan 1, 1976·Annals of the New York Academy of Sciences·R Pirskanen
Apr 1, 1979·Neurology·J Keesey, S Novom
Nov 1, 1977·The American Journal of Medicine·C L MastersR J Leedman
Nov 1, 1980·Neurology·J W AlbersW L Treacy
Oct 1, 1983·Annals of the Rheumatic Diseases·J P DelamereK W Walton
Nov 14, 1981·British Medical Journal·J C WoodrowG Zaphiropoulos
Jan 1, 1983·Immunological Reviews·R L DawkinsP J Zilko
Feb 1, 1982·Archives of Neurology·J KeeseyR Walford
Aug 1, 1982·Annals of the Rheumatic Diseases·B SchiffE Gazit
Dec 1, 1980·Ryūmachi. [Rheumatism]·M Hokonohara
Jul 1, 1981·Muscle & Nerve·M J GarleppA Kemp
Apr 1, 1980·Arthritis and Rheumatism·C F TorresA S Penn

❮ Previous
Next ❯

Citations

Sep 1, 1994·Clinical Rheumatology·P Seideman, R Ayesh
Dec 1, 1994·Clinical Rheumatology·A P AndonopoulosT Papapetropoulos
Jun 1, 1986·Journal of Neuroimmunology·L S KlavinskisJ Newsom-Davis
Feb 1, 1992·Journal of Neuroimmunology·J B KuksH J Oosterhuis
Dec 1, 1984·Journal of Neuroimmunology·F T ChristiansenR L Dawkins
Nov 25, 1993·Nucleic Acids Research·C MacLennanJ Newsom-Davis
Sep 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·J George, E G Spokes
Jul 7, 2010·Pharmacogenomics·Elizabeth J Phillips, Simon A Mallal
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Rebecca PavlosElizabeth Phillips
Sep 1, 1993·Journal of Neuroimmunology·E Tournier-Lasserve, J F Bach
Jan 1, 1992·Scandinavian Journal of Rheumatology·D Bauer-VinassacJ P Escande
Apr 1, 1993·Journal of the American Academy of Dermatology·E JonesN M Walsh
Aug 9, 2015·The Journal of Allergy and Clinical Immunology·Aaron W Michels, David A Ostrov
Jul 20, 2007·Developmental Medicine and Child Neurology·J R Parr, S Jayawant
Nov 1, 1996·Journal of the American Academy of Dermatology·A Bialy-Golan, S Brenner
Oct 1, 1993·Clinics in Dermatology·N Mobini, A R Ahmed
May 1, 1986·Seminars in Arthritis and Rheumatism·H E Howard-LockW F Kean
Jan 1, 1987·Microbiology and Immunology·H WatanabeR L Dawkins
Jan 1, 1987·Annals of the New York Academy of Sciences·J Newsom-DavisJ Burges
Jan 1, 1987·Annals of the New York Academy of Sciences·R L DawkinsF T Christiansen
Jul 11, 2001·Lancet·A VincentD Hilton-Jones
Jul 21, 1998·Annals of the New York Academy of Sciences·A S PennJ J Jacques
Aug 1, 1995·European Journal of Haematology·K KrishnanP T Adams
Oct 1, 1994·Clinical and Experimental Immunology·M J GarleppF L Mastaglia
Jan 6, 1986·The Medical Journal of Australia·K D Muirden
Nov 1, 1994·Survey of Ophthalmology·D A WeinbergT L Vollmer
Apr 1, 1991·Baillière's Clinical Rheumatology·P J RooneyP Petrou
May 1, 1988·The American Journal of the Medical Sciences·J D Smiley, S E Moore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.